Viewpoint: Precision medicine promises a lot, but has delivered little

Print Friendly, PDF & Email
fg logo
Image credit: Sidra Medicine

Doctors and hospitals love to talk about the patients they’ve saved with precision medicine, and reporters love to write about them. But the people who die still vastly outnumber the rare successes.

There has been real progress, of course. Testing for genetic mutations has become standard in lung cancer, melanoma and a handful of other tumor types. But the number of people with advanced cancer eligible for these approaches is just 8 percent to 15 percent, experts estimate. And these targeted therapies help about half of patients who try them.

At the most recent meeting of the American Society of Clinical Oncology, researchers presented four precision-medicine studies. Two were total failures. The others weren’t much better, failing to shrink tumors 92 percent and 95 percent of the time. The studies received almost no news coverage.

Related article:  With glyphosate-cancer legal battles poised to escalate, what are the ramifications for agriculture if the herbicide is restricted?

Hospitals promote their precision-medicine programs by showcasing the stories of long-term survivors. Companies that sell the tests that look for mutations — such as Foundation MedicineCaris Life Sciences and Guardant Health — highlight only the best-case scenarios.

Against this backdrop of hope and desperation, how are patients supposed to make informed decisions?

The phrase “precision medicine” suggests a high rate of success. While its successes should be celebrated, its failures must be acknowledged, reminding us how much is left to learn.

Read full, original post: Are We Being Misled About Precision Medicine?

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

Infographic: Trending green and going great — Every state in the US seeing decreased cases of COVID

The U.S. averaged fewer than 40,000 new cases per day over the past week. That’s a 21% improvement over the ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists